Market
-
Aaron’s limps through after-hours trade on Q4 loss, downbeat 2024 guidance (AAN)
Shares of The Aaron’s Company (NYSE:AAN) are in a freefall in after-hours trade as the company’s swung to a loss in the fourth quarter and projected a loss for 2024 that is significantly worse than Street expectations. The company reported a loss of $0.26 per share on a 10.2% drop in revenue to $529.5M. This compares to a profit of…
Read More » -
Bayer to slash dividend by 95% to reduce its debt
NoDerog Bayer AG (OTCPK:BAYZF) plans to shrink its dividend by 95% as it works to reduce debt. Bayer shares rose about 1% in Germany on Monday after the dividend cut was disclosed. The German healthcare and crop sciences conglomerate said it will reduce its dividend policy to pay out the legally required minimum for three years, according to a statement…
Read More » -
JetBlue stock soars after Icahn discloses stake
JetBlue stock soars after Icahn discloses stake Source link
Read More » -
Flywire gets Buy rating from Deutsche after recent weakness (NASDAQ:FLYW)
pp76/iStock via Getty Images Deutsche Bank analyst Nate Svensson started coverage of Flywire Corp. (NASDAQ:FLYW) stock with a Buy rating on Monday after recent selling pressure has created a good buying opportunity for investors. Since the start of 2024, FLYW has shed 7.3%. From a year ago, the stock retreated 19.6%. At five times his 2025 EV/gross profit estimate, FLYW…
Read More » -
Gilead invests $320M in Arcus, expands stake to 33% (NYSE:RCUS)
Sundry Photography Arcus Biosciences (NYSE:RCUS) shares jumped 16% in post-market trading Monday following news that partner Gilead Sciences (NASDAQ:GILD) has increased its stake in the company to 33% to help accelerate their joint development programs. Gilead upped its stake by buying $320M shares of Arcus at $21 per share. The deal entitles Gilead to an additional seat on Arcus’s board,…
Read More »